Mostrar Notícias:

ABTPrincipaisÚltima HoraBovespa - Brasil

 Ver notícias de outros activos

Pesquisa de notícias relativas à acção Abbott Laboratori (ordenadas pela data):

BNET

Abbott on Acquisition Spree Zacks.com Abbott (ABT - Analyst Report) continues to be in an acquisition mode, recently announcing its intention to acquire Facet Biotech Corporation (FACT ... Abbott To Acquire Facet Biotech For $27 Per Share In Cash - Quick FactsRTT News Facet Biotech Stock Soars on Abbott BidTheStreet.com Facet Biotech Has $722M That Says It Pays to Stand Up to BulliesBNET Forbes -Reuters -Wall Street Journal all 450 news articles »

Abbott, Pfizer Lead Drug Stocks Lower Wall Street Journal Shares of Abbott (ABT) were down 3% at $54.00. Early Friday, analysts at Citigroup cut their rating of Abbott's stock to sell from hold. ... Abbott leads drugs stocks lowerMarketWatch Abbott Laboratories (ABT) Chairman and CEO Miles D White sells 70700 SharesGuruFocus.com Citigroup Downgrades Abbott Laboratories on Profitability Issues; Target $52 (ABT)Comtex Smartrend istockAnalyst.com (press release) -FOXBusiness all 21 news articles »

Hospira Is a Classic Successful Spin-Off Stock Seeking Alpha (blog) His clients wanted to stick with Abbott (ABT) the parent company. They didn't want the new company's stock, so they sold it. And, while they were doing that ...

Share this page Seeking Alpha (blog) Dividends are being raised all over the place by firms like Coke (KO), Wal-Mart (WMT), Pepsico (PEP), Rogers, Abbott (ABT), and the most bullish of all. ... Comfort Zone Investing: Why GE's Dividend Increase MattersBloggingStocks (blog) all 2 news articles »

Last day of trading for StarLIMS Globes From tomorrow, the company will be part of the diagnostics division of Abbott Laboratories Inc. (NYSE: ABT). StarLIMS was founded by CEO Itschak Friedman ... and more »

Abbott CEO White's Total Compensation Falls 7% In 2009 Wall Street Journal Abbott Laboratories (ABT) Chief Executive Miles D. White saw the value of his total compensation slip 7% last year, but he still pulled in $26.2 million, ... Abbott CEO's pay falls on reduced stock optionsThe Associated Press Abbott CEO pay drops 7% to $26.2MFiercePharma Abbott Labs CEO gets 3% raise, $3.9 million bonusChicago Breaking Business - Tribune all 121 news articles »

Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular ... Advertiser Talk ATLANTA ? Abbott (NYSE: ABT) today announced positive 30-day results from the first 101 patients enrolled in the second phase of the ABSORB trial. ...

VIX has no place in stock picks, report says Chicago Sun-Times THE ABBOTT LADY: Two weeks ago, I wrote about Grace Groner, whose mid-1930s purchase of three shares of Abbott Laboratories (ABT) turned into a $7 million ... and more »

Axis-Shield FY pretax profit up, sees maiden div in '10 Reuters ... also said it agreed to repurchase full US marketing rights for its Afinion devices from Abbott Diagnostics, the UK unit of Abbott Laboratories Inc (ABT. ... Axis-Shield gets back rights for Afinion in USATrading Markets (press release) all 18 news articles »

New York Daily News

Abbott's heart valve device proves safe, effective Reuters Abbott Laboratories (ABT.N) is hoping to use the data to win US approval for the mitral valve repair device. Its MitraClip has been available in Europe for ... Abbott Heart Valve-Repair Tool Meets Goals In StudyWall Street Journal Abbot's MitraClip Heart Valve Repair Device Proven Effective, Safe (ABT)Trading Markets (press release) Abbott's MitraClip Heart Valve Repair Device Meets Primary Safety ...RTT News Minyanville.com -PR Newswire (press release) -Forbes all 446 news articles »

AsiaOne

Abbott's TriCor Shows No Benefit For Diabetics In Study Wall Street Journal Abbott Laboratories' (ABT) cholesterol drug TriCor failed to significantly reduce the risk of heart attacks and ... Abbott Labs TriCor Mixed With Simvastatin Failed To Reduce Risks For Diabetics ...Benzinga No heart benefit seen with fibrates in diabeticsReuters Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for ...Trading Markets (press release) all 94 news articles »

Abbott Laboratories? ABSORB Trials Positive; Trilipix Patent Challenged FOXBusiness Abbott Laboratories (ABT) announced Monday that it has seen positive results from the first 30 days of second-phase trials for ABSORB, ... Impax challenges patent on Abbott's TrilipixBusinessWeek Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular ...PR Newswire (press release) Bay Biz Buzz: Abbott Labs sues Hayward's ImpaxContra Costa Times RTT News -Bizjournals.com -Pharmaceutical Online (press release) all 55 news articles »

Washington Post

No Signs Of Intelligent Life At Boston Scientific 24/7 Wall St. (blog) Abbott (ABT) and Medtronic (MDT) have picked up market share in the stent business over the last two years. Boston Scientific is in such bad shape now in ... UBS Maintains a 'Buy' Rating on Boston Scientific (BSX); Adjusts Estimates & PTStreetInsider.com (subscription) A Lesson from Boston ScientificGuruFocus.com PulseCheck: Boston Scientific Needs a DefibrillatorSeeking Alpha (blog) Zacks.com all 565 news articles »

Forbes (blog)

Spotlight On Abbott Heart Drug, New Device At Conference Wall Street Journal A veteran Abbott Laboratories (ABT) cholesterol drug and a new Abbott heart-repair tool will take center ... Abbott's High-Stakes WeekendForbes (blog) all 5 news articles »

Abbott Buys Facet to Strengthen Biologics Capabilities, Pharma Pipeline Seeking Alpha (blog) Abbott (ABT) has acquired antibody expert Facet Biotechnology (FACT) for $722 million, which includes Facet's projected cash and marketable securities, ... After the FACT. Why I didn't buy Facet biotech and why I should have?maybe.Motley Fool (blog) A Lukewarm IPO, White Knight Spice Up Biotech's Latest DealsSeeking Alpha (blog) all 3 news articles »

TopNews United States

Merck falls on Zocor warning Investor's Business Daily Simvastatin is also part of Merck's Vytorin and Abbott Labs' (ABT) Simcor, and is sold by other drugmakers like Teva (TEVA). Merck fell 1% to 38.06. FDA issues warning for high doses of ZocorReuters FDA warns of greater muscle risk from ZocorONN.tv US FDA warns about increased risk of muscle injury with ZocoristockAnalyst.com (press release) all 295 news articles »

UK favours Humira, Enbrel for psoriatic arthritis Reuters LONDON, March 15 (Reuters) - Abbott Laboratories' (ABT.N) drug Humira and Enbrel, from Pfizer (PFE.N) and Amgen (AMGN.O), should be the first choices for ... UK Body Backs Enbrel, Humira In Psoriatic Arthritis TreatmentWall Street Journal NICE taps Humira, Enbrel as first-line meds; Elan gave J&J an option on ...FiercePharma all 10 news articles »

Abbott Says No Cardiovascular Benefit Seen With Fenofibrate In Diabetics RTT News (RTTNews) - Healthcare company Abbott Laboratories (ABT: News ) said Sunday that the primary endpoint of the ACCORD study was not met. ... and more »

One woman, three Abbott shares equals $7 million Chicago Sun-Times Groner graduated from Lake Forest College in 1931 with a degree in English and went to work at Abbott Laboratories (ABT), where she stayed 43 years and ... and more »

Abbott, Enanta moving Hepatitis C drug development BusinessWeek Also moving into midstage development are ABT-333 and ABT-072, which were both discovered by Abbott. The midstage studies will focus on safety, tolerability ... Abbott, Enanta hopes hepatitis C drug will boost marketDrug Store News (blog) Enanta advances joint HCV drug to Phase 2 trialsMass High Tech Abbott and Enanta Announce Advancement of Hepatitis C CollaborationMarketWatch (press release) Aidsmap -Psychiatric Services (subscription) -7thSpace Interactive (press release) all 39 news articles »

French biotech Neovacs targets 20 million euros in IPO Reuters N) or Abbott (ABT.N) are already on the TNF-alpha market. Gementech DNA.N, AstraZeneca (AZN.L) or Novo Nordisk (NOVOb.CO) are on the interferon alpha ... and more »

Stocks leaning toward gains CNNMoney.com ... such as Abbott Labs' (ABT, Fortune 500) acquisition of Facet Biotech and J. Crew's (JCG) report that revenue jumped 19% in the fourth quarter. ... Daily Stock AlertBarron's (blog) US STOCKS-S&P gains as financials' outlook improves; Dow dipsReuters Stocks get lift from inventories; financials leadInvestor's Business Daily all 1,715 news articles »

? Abbott Labs: Dividend Stock Analysis Seeking Alpha (blog) While there are periods in which I would agree with your comment related to ABT, the last four years is not one of them. On pure share growth alone, ...

Reuters

Breast cancer study aims to speed drugs, cooperation Reuters ABT-888 or veliparib, being developed by Abbott Laboratories (ABT.N). The pill is a PARP inhibitor, which blocks a cell repair enzyme used by cancer cells. ... US plans to speed personalized breast cancer drugs to marketFlesh and Stone Breast Cancer Study Targets Early Marketing Of DrugsVisit Bulgaria all 164 news articles »

National Post

Drug-Coated Stent Market May Need New Devices To Boost Usage NASDAQ (BSX), Abbott Laboratories (ABT), Medtronic Inc. (MDT) and Johnson & Johnson (JNJ) are the main manufacturers. Four years ago, coated stents were used ... Long-term safety of drug-coated stents questionedReuters all 20 news articles »

Boston Scientific's new stent good as the old one Reuters ... a platinum chromium alloy, with its older Taxus Express stent, which has been losing market share to competitors, including Abbott Laboratories' (ABT. ... UPDATE: Stents war heats up at ACC conferenceMass Device New Boston Scientific Stent Matches Old One In StudyNASDAQ Boston Scientific Gets Approval - Analyst BlogBenzinga all 186 news articles »

BG Medicine and Abbott to Develop Galectin-3 Test for the i-STAT(R) System MarketWatch (press release) WALTHAM, Mass., Mar 08, 2010 (BUSINESS WIRE) -- BG Medicine, Inc. today announced that it has entered into an agreement with Abbott Laboratories (NYSE:ABT) ... BG Medicine, Abbott partner on heart attack mortality testMass Device Abbott to Use BG Medicine's Heart-Failure Biomarker in Point-of-Care TestGenetic Engineering News (press release) all 16 news articles »

Neurosearch posts 2009 loss, plans active 2010 Reuters Neurosearch's partners include Abbott Laboratories (ABT.N) in a programme to develop a treatment for attention deficit hyperactivity disorder (ADHD) in ... and more »

US STOCKS-Markets edge higher after M&A activity Reuters For details, see [ID:nN10228689] Abbott Laboratories (ABT.N) agreed to buy Facet Biotech Corp (FACT.O) for $27 a share late Tuesday, topping a failed bid ... and more »

FDA Approvals: Allergan, Abbott MarketNewsVideo.com And today, Abbott Laboratories (NYSE:ABT) received approval from the FDA for its Tecnis Multifocal 1-Piece intraocular lens for cataract patients. ... and more »